3139 results for «901»
3139 results
Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover different surgical and transcatheter approaches:
- Part 1: Bioprosthesis aortic valve stenosis
A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
During the live time...
Valve-in-valve TAVI: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...
Challenging scenarios: bicuspid aortic valves
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.
TAVI in patients at risk of coronary occlusion
28 Nov 2022 – From PCR London Valves 2022
Consult this session on TAVI in patients at risk of coronary occlusion to discover a selection of cases presented during PCR LV 2022: hyperacute obstruction of the left main artery due to calcium displacement during TAVR, cannulation technique for challenging coronary access following TAVI-in-TAVI, complex TAVI from...
How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair
28 Nov 2022 – From PCR London Valves 2022
Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!
Mitral: new devices and procedural refinements
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of cases regarding mitral new devices: transapical mitral valve implantation for treatment of symptomatic mitral valve disease, transcatheter edge-to-edge mitral valve repair for atrial functional mitral regurgitation, and much more!
Transcatheter mitral valve interventions: clinical outcomes 1
28 Nov 2022 – From PCR London Valves 2022
Consult this session on transcatheter mitral valve interventions to discover a selection of abstracts submitted during PCR London Valves 2022: one-year outcomes for transcatheter mitral repair from the MiCLASP study, the Edwards PASCAL transcatheter mitral valve repair system study, one-year outcomes of Tendyne TMVR treating symptomatic MR,...
Rapid-fire abstracts: Session 6
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
Rapid-fire clinical cases: Session 4
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
Rapid-fire abstracts: Session 9
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...
Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...
How to achieve safe early discharge
29 Nov 2022 – From PCR London Valves 2022
Discover how to achieve safe early discharge for TAVI patients with these presentations: learn more about the need of pre-procedural planning and active post-procedural care, which ECG reading are a cause for concern, and much more!
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
Mitral valve in mitral annular calcification (MAC) - Recorded case
27 Nov 2022 – From PCR London Valves 2022
A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...
The multidisciplinary structural heart team - How do we include the patient
27 Nov 2022 – From PCR London Valves 2022
Consult this session on the multidisciplinary structural heart team to learn more about the evolving role of the team and how this affects decision making, to discover why patient advocacy and partnership is vital within the team, as well as to identify potential barriers and enablers of the future...
Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case
28 Nov 2022 – From PCR London Valves 2022
- Part 1: Primary MR repair (recorded case)
An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE. - Part 2: Tricuspid valve in valve (Live case)
A 52-year-old female, with diabetes and...
Challenging scenarios: acute coronary obstruction
28 Nov 2022 – From PCR London Valves 2022
Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.
Patient selection for tricuspid valve interventions
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.
